Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
❓ Unknown

Long-acting Injectable Antipsychotics Show Superior Efficacy in Older Schizophrenia Patients

Just now September 25, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

A research team from the University of Hong Kong has discovered that long-acting injectable antipsychotics are more effective than oral medications for treating schizophrenia in patients aged 65 and older. This finding could influence treatment protocols in Iran, particularly for its aging population with mental health issues. Improved mental health care is crucial for the overall well-being of Iranian society.

🔍 Quick Context Guide
💡 Bottom Line: The findings could reshape treatment protocols for schizophrenia in Iran, benefiting the aging population.

👥 Key Players

University of Hong Kong (HKUMed) MENTIONED
Research Institution
"HKUMed is a leading institution in medical research, influencing treatment protocols globally, including in Iran."
Older Patients with Schizophrenia MENTIONED
Patient demographic
"This group is often underserved in mental health care, and improved treatment options can significantly enhance their quality of life."

📰 What Happened

Researchers at the University of Hong Kong found that long-acting injectable antipsychotics are more effective than oral medications for treating schizophrenia in patients aged 65 and older. This discovery could lead to changes in treatment practices, especially in countries with aging populations like Iran.

  • Long-acting injectable antipsychotics showed superior efficacy in older patients.
  • The study focuses on patients aged 65 and older, a demographic that often faces unique challenges in mental health treatment.

💡 Why It Matters

🇮🇷 For Iran: Iran's aging population is growing, and effective mental health treatments are crucial for societal well-being and healthcare efficiency.
🌍 Regional: Improved mental health care could lead to better overall health outcomes in the Middle East, where mental health issues are often stigmatized.
🌐 International: This research may prompt global discussions on mental health treatment standards, particularly for elderly patients.

📚 Background

Schizophrenia is a chronic mental health condition that can severely impact daily functioning, especially in older adults. Long-acting injectable antipsychotics offer a potential solution by improving adherence to treatment.

Mental health care in aging populations Antipsychotic medication efficacy
📡 Source: NEUTRAL
📊 Confidence: 70%
The source is a reputable academic institution, providing reliable and scientifically-backed information.

A research team from the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has found that long-acting injectable (LAI) antipsychotics provide better treatment outcomes than oral antipsychotic medications for patients 65 and older with schizophrenia.

🏷️ Entities Mentioned

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →